Additional bedtime H2-receptor antagonist for the control of nocturnal gastric acid breakthrough

Author:

Wang Yiping1,Pan Tao2,Wang Qiong3,Guo Zhen1

Affiliation:

1. West China Hospital, Sichuan University; Department of Digestive Disease; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

2. West China Hospital, Sichuan University; Department of Gastroenterology; No. 37, Guo Xue Xiang Chengdu Sichuan China 610041

3. The Third People's Hospital; Department of Digestive Disease; Chengdu Sichuan China

Publisher

Wiley

Subject

Pharmacology (medical)

Reference44 articles.

1. The relationship and clinical meaning of nocturnal gastric acid breakthrough and acid exposure of esophagus;Bing;New Chinese Medicine,2005

2. Clinical investigation into nocturnal acid breakthrough in patients with duodenal ulcer;Cong;Chinese Journal of Practical Internal Medicine.,2004

3. Clinical study of nocturnal acid breakthrough in old patients with duonenal ulcer;Cong;World Chinese Journal of Digestology,2004

4. Treatment for nocturnal acid breakthrough;Hong;New Chinese Medicine,2002

5. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis-a randomized controlled, cross-over trial;Janiak;Alimentary Pharmacology and Therapeutics,2007

Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Refractory Gastroesophageal Reflux Disease: Diagnosis and Management;Journal of Neurogastroenterology and Motility;2024-01-30

2. Acid‐suppressive drugs: A systematic review and network meta‐analysis of their nocturnal acid‐inhibitory effect;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2023-12-12

3. Medical Therapy for Gastroesophageal Reflux Disease;Gastroesophageal Reflux Disease;2023

4. 2020 Seoul Consensus on the Diagnosis and Management of Gastroesophageal Reflux Disease;Journal of Neurogastroenterology and Motility;2021-10-30

5. Histamine in cancer immunology and immunotherapy. Current status and new perspectives;Pharmacology Research & Perspectives;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3